| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052321 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 03/09/2006 | US20060052307 Bone growth factor |
| 03/09/2006 | US20060052302 coagulants is a drug/polymer conjugates/, contains blood-coagulation factor IX covalently attached through a spacer moiety to a endcapped polyethylene glycol; blood disorders |
| 03/09/2006 | US20060052301 Splice variants of peptide YY, neuropeptide Y, pancreatic peptide Y and Amylin, and uses thereof |
| 03/09/2006 | US20060052299 Mntf peptides and compositions and methods of use |
| 03/09/2006 | US20060052294 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060052292 Adiponectin fragments and conjugates |
| 03/09/2006 | US20060052291 Chemically-modified progenipoietin conjugates |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060052284 Novel peptide conjugates |
| 03/09/2006 | US20060052282 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 03/09/2006 | US20060052281 Protein s protects the nervous system from injury |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051869 Transport proteins and their uses |
| 03/09/2006 | US20060051861 Cell lines for use in increasing protein yield from a cell culture |
| 03/09/2006 | US20060051859 Long acting human interferon analogs |
| 03/09/2006 | US20060051851 Novel selenocysteine-containing protein |
| 03/09/2006 | US20060051850 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/09/2006 | US20060051844 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 03/09/2006 | US20060051843 Fluorescent protein for use as resolution tools in genetic analysis |
| 03/09/2006 | US20060051842 Nucleic acid encoding alpha chain of human IL-11 receptor |
| 03/09/2006 | US20060051840 Hybrid expression of neisserial proteins |
| 03/09/2006 | US20060051839 DNA expression vectors and methods of use |
| 03/09/2006 | US20060051837 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051835 Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease |
| 03/09/2006 | US20060051834 Method for preparative in vitro protein biosynthesis |
| 03/09/2006 | US20060051823 specific antigenic proteins and peptides unique to Treponema pallidum; diagnosis of syphilis; immunoassay of acidic repeat protein/immunogens |
| 03/09/2006 | US20060051822 Methods for detecting Bacillus thuringiensis cryET33 and cry ET34 polypeptides |
| 03/09/2006 | US20060051811 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 03/09/2006 | US20060051810 Kit for diagnosing GH deficiency |
| 03/09/2006 | US20060051808 Tumor related Dkk genes, proteins; host cells, vectors |
| 03/09/2006 | US20060051806 Diagnosing blood disorder via presence of missense mutation in hemochromatosis gene |
| 03/09/2006 | US20060051797 Novel testis-specific genes in avian species |
| 03/09/2006 | US20060051792 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051781 Nucleic acid encoding DS-CAM proteins and products related thereto |
| 03/09/2006 | US20060051779 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051774 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/09/2006 | US20060051772 SSX-4 peptides presented by HLA class II molecules |
| 03/09/2006 | US20060051767 By modulating acetylation of cytochrome c, cytochrome c induced cellular processes such as apoptosis and mitochondrial function (e.g., respiration) can be modulated; modulation of cytochrome c acetylation with SIR polypeptide enables interventions that modulate lifespan regulation and cell proliferation |
| 03/09/2006 | US20060051759 Compositions and methods relating to breast specific genes and proteins |
| 03/09/2006 | US20060051758 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051747 infecting human embryonic retinoblast with an influenza virus, then culturing and allowing for expression of said influenza virus and influenza viral protein, and harvesting influenza virus and/or influenza viral protein uses as vaccines |
| 03/09/2006 | US20060051746 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/09/2006 | US20060051745 HCV non-structural protein mutants and uses thereof |
| 03/09/2006 | US20060051743 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/09/2006 | US20060051742 Novel assay for the separation and quantification of hemagglutinin antigens |
| 03/09/2006 | US20060051739 Methods and composition for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 03/09/2006 | US20060051379 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 03/09/2006 | US20060051373 Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods |
| 03/09/2006 | US20060051371 immunogenic non-haemolytic strain of Actinobacillus pleuropneumoniae which is modified in segment of apxIA gene and optionally in segment of apxIIA gene that encodes transmembrane domain of Apx haemolytic and cytolytic exotoxins; comprises also strains and attenuated live vaccine porcine pleuorpneumonia |
| 03/09/2006 | US20060051368 Herpes simplex virus mutations |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051365 Immunogenic composition |
| 03/09/2006 | US20060051364 Purified salivary Lu. longipalpis polypeptides, and polynucleotides encoding these; vectors and host cells; inducing an immune response to sand fly saliva; diagnosing or preventing Leishmaniasis; genetic engineering |
| 03/09/2006 | US20060051363 Protein inducing cell death of helicobacter pylori |
| 03/09/2006 | US20060051362 Antigens for actinobacillus pleuropneumoniae and methods thereof |
| 03/09/2006 | US20060051360 Non-denatured, recombinant human immunodeficiency virus (HIV) Tat that is free of bacterial RNA and endotoxin; |
| 03/09/2006 | US20060051359 Recombinant immunotoxin and use in treating tumors |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051351 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051343 Preventives remedies for bone and joint diseases |
| 03/09/2006 | US20060051335 fusing cells: nucleic acid vector comprises a nucleotide sequence encoding a syncytium-inducing polypeptide that is expressible on a eukaryotic cell surface and comprises a sequence of a gibbon ape leukemia virus |
| 03/09/2006 | US20060051333 AAV virions with decreased immunoreactivity and uses therefor |
| 03/09/2006 | US20060051331 Optimization of transgene expression in mammalian cells |
| 03/09/2006 | US20060051325 Isolation and use of solid tumor stem cells |
| 03/09/2006 | US20060051292 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 03/09/2006 | DE102004043782A1 Polypeptide und Verfahren zur spezifischen Bindung von Prionen Polypeptides and methods for the specific binding of prions |
| 03/09/2006 | DE102004040370A1 Verfahren zur Identifizierung atypischer p-ANCA A method for identifying atypical p-ANCA |
| 03/09/2006 | DE10046932B4 Expressionssystem zur Überexpression von Kupfer-abhängigen sekretierten Proteinen in eukaryontischen Zellen Expression system for overexpression of copper-dependent secreted proteins in eukaryotic cells |
| 03/09/2006 | CA2797666A1 Peptide derivatives of exendin-3 |
| 03/09/2006 | CA2594672A1 Methods and compositions to inhibit p2x7 receptor expression |
| 03/09/2006 | CA2591532A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 03/09/2006 | CA2579094A1 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/09/2006 | CA2578911A1 Degradable clostridial toxins |
| 03/09/2006 | CA2578904A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 03/09/2006 | CA2578403A1 Recombinant mva viruses expressing clade a/g, clade b, and clade c modified hiv, gag and pol genes |
| 03/09/2006 | CA2578252A1 Glp-1 and exendin related invention |
| 03/09/2006 | CA2578041A1 Fusobacterium polypeptides and methods of use |
| 03/09/2006 | CA2578014A1 Domains and epitopes of meningococcal protein nmb1870 |
| 03/09/2006 | CA2577950A1 Novel phosphorylated phosphatase cdc25b sequences, antibodies directed against said sequences and uses thereof |
| 03/09/2006 | CA2577134A1 A purified arabinogalactan-protein (agp) composition |
| 03/09/2006 | CA2576813A1 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxy acid synthase large subunit proteins comprising a p182l and uses thereof |
| 03/09/2006 | CA2576798A1 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/09/2006 | CA2575675A1 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
| 03/09/2006 | CA2575481A1 Disarmed agrobacterium strains, ri-plasmids, and methods of transformation based thereon |
| 03/08/2006 | EP1632778A2 Natural ligand of gpcr chemr23 and uses thereof |
| 03/08/2006 | EP1632574A1 Fibroblast growth factor homologs |
| 03/08/2006 | EP1632573A2 Modulation of sodium channels in dorsal root ganglia |
| 03/08/2006 | EP1632564A1 Vaccine against severe accute respiratory syndrome causing coronavirus (SARS-CoV) |
| 03/08/2006 | EP1632502A1 Methods of detecting collagen degradation in vivo |